InflaRx N.V. (IFRX) EPS Estimated At $-0.62; Wealthtrust Fairport Has Decreased Its Fidelity Natl Information Sv (FIS) Position

Fidelity National Information Services, Inc. (NYSE:FIS) Logo

Analysts expect InflaRx N.V. (NASDAQ:IFRX) to report $-0.62 EPS on May, 16.They anticipate $0.13 EPS change or 26.53% from last quarter’s $-0.49 EPS. After having $-0.46 EPS previously, InflaRx N.V.’s analysts see 34.78% EPS growth. The stock decreased 1.10% or $0.46 during the last trading session, reaching $41.39. About 78,672 shares traded. InflaRx N.V. (NASDAQ:IFRX) has risen 39.39% since May 15, 2018 and is uptrending. It has outperformed by 35.02% the S&P500. Some Historical IFRX News: 08/05/2018 – InflaRx N.V. Announces Closing of Primary and Secondary Offering of Common Shrs; 08/03/2018 – INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE llB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA; 17/05/2018 – InflaRx 1Q Loss/Shr EUR0.04; 08/05/2018 – INFLARX N.V. REPORTS CLOSING OF PRIMARY, SECONDARY OFFERING; 08/03/2018 – lnflaRx announces first patient enrolled in Phase llb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 08/03/2018 InflaRx announces first patient enrolled in Phase IIb trial with lead candidate IFX-1 in Hidradenitis Suppurativa; 17/05/2018 – InflaRx 1Q Loss EUR10.3M; 29/03/2018 – InflaRx Full Year 2017 Financial & Operating Results; 29/03/2018 – InflaRx FY Loss/Shr EUR2.6; 03/05/2018 – INFLARX PRIMARY, SECONDARY OFFERINGS PRICES AT $34.00 PER SHARE

Wealthtrust Fairport Llc decreased Fidelity Natl Information Sv (FIS) stake by 5.49% reported in 2018Q4 SEC filing. Wealthtrust Fairport Llc sold 3,927 shares as Fidelity Natl Information Sv (FIS)’s stock declined 0.58%. The Wealthtrust Fairport Llc holds 67,662 shares with $6.94M value, down from 71,589 last quarter. Fidelity Natl Information Sv now has $37.84B valuation. The stock increased 1.27% or $1.47 during the last trading session, reaching $116.92. About 2.83M shares traded. Fidelity National Information Services, Inc. (NYSE:FIS) has risen 11.84% since May 15, 2018 and is uptrending. It has outperformed by 7.47% the S&P500. Some Historical FIS News: 08/05/2018 – FIDELITY NATIONAL TARGETS 2021 EPS OF $7-$7.50: SLIDES; 30/04/2018 – Fidelity Series Selector Large Cap Value Adds Fidelity National; 01/05/2018 – Fidelity National Raises 2018 View To Adj EPS $5.14-Adj EPS $5.34; 09/04/2018 – Fidelity National: Martire to Pursue Other Interests; 01/05/2018 – Fidelity National 1Q Rev $2.1B; 14/05/2018 – NEW DEAL: Fidelity National $1b WNG 10Y +145a, 30Y +190a; 09/04/2018 – Fidelity National Information Chairman Frank Martire to Retire; 11/04/2018 – FIS Recognizes Ten Clients for Innovation in 2018 Impact Awards; 31/05/2018 – New Research Coverage Highlights Constellation Brands, Yintech Investment, EZCORP, Euronet Worldwide, Fidelity National Financi; 09/03/2018 – FIS Wins Awards for Sales, Customer Service and Business Process Outsourcing

More notable recent Fidelity National Information Services, Inc. (NYSE:FIS) news were published by: Seekingalpha.com which released: “FIS jumps 3.3% after FY2019 revenue guidance boost – Seeking Alpha” on April 30, 2019, also Seekingalpha.com with their article: “Fidelity National Information Services, Inc. (FIS) CEO Gary Norcross on Q1 2019 Results – Earnings Call Transcript – Seeking Alpha” published on April 30, 2019, Businesswire.com published: “Direct-to-Consumer Banks Overtake Traditional Banks in Customer Satisfaction, New FIS Study Shows – Business Wire” on April 16, 2019. More interesting news about Fidelity National Information Services, Inc. (NYSE:FIS) were released by: Seekingalpha.com and their article: “Fidelity National Q1 2019 Earnings Preview – Seeking Alpha” published on April 29, 2019 as well as Businesswire.com‘s news article titled: “FIS Recognizes Ten Clients for Innovation in 2019 Impact Awards – Business Wire” with publication date: April 17, 2019.

Investors sentiment decreased to 1.01 in 2018 Q4. Its down 0.06, from 1.07 in 2018Q3. It fall, as 49 investors sold FIS shares while 191 reduced holdings. 59 funds opened positions while 183 raised stakes. 284.19 million shares or 1.79% more from 279.20 million shares in 2018Q3 were reported. Bnp Paribas Asset Management Holdings Sa invested in 0.06% or 68,883 shares. Kayne Anderson Rudnick Inv Management Ltd Liability invested in 94,897 shares. Korea Inv Corp holds 67,547 shares. Moreover, Next Group has 0% invested in Fidelity National Information Services, Inc. (NYSE:FIS). Deutsche Bancorporation Ag holds 961,967 shares. Serv Automobile Association owns 297,020 shares. 3,801 were accumulated by Smithfield. 366 are held by Cornerstone Advisors. Royal London Asset Management Ltd reported 0.12% stake. Public Employees Retirement Association Of Colorado owns 0.04% invested in Fidelity National Information Services, Inc. (NYSE:FIS) for 59,517 shares. New York-based Hudson Bay Cap Mngmt LP has invested 0.02% in Fidelity National Information Services, Inc. (NYSE:FIS). Tortoise Investment Mgmt Ltd Liability Corp holds 0% of its portfolio in Fidelity National Information Services, Inc. (NYSE:FIS) for 15 shares. Jfs Wealth Advsrs Ltd Liability Com accumulated 252 shares. Howe Rusling accumulated 40,346 shares. Robeco Institutional Asset Mngmt Bv has invested 0.12% in Fidelity National Information Services, Inc. (NYSE:FIS).

Among 9 analysts covering Fidelity National Info (NYSE:FIS), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Fidelity National Info has $140 highest and $118 lowest target. $129.90’s average target is 11.10% above currents $116.92 stock price. Fidelity National Info had 15 analyst reports since December 11, 2018 according to SRatingsIntel. Raymond James maintained the stock with “Strong Buy” rating in Friday, April 12 report. Guggenheim maintained the shares of FIS in report on Friday, March 22 with “Buy” rating. The rating was maintained by Oppenheimer on Tuesday, March 26 with “Buy”. The firm has “Buy” rating by Robert W. Baird given on Wednesday, March 20. The stock of Fidelity National Information Services, Inc. (NYSE:FIS) earned “Overweight” rating by Barclays Capital on Wednesday, April 10. The stock of Fidelity National Information Services, Inc. (NYSE:FIS) has “Buy” rating given on Monday, March 18 by Cantor Fitzgerald. Wedbush maintained the stock with “Outperform” rating in Friday, March 22 report. Goldman Sachs upgraded it to “Buy” rating and $128 target in Tuesday, December 11 report.

Wealthtrust Fairport Llc increased Select Sector Spdr Tr (XLI) stake by 8,362 shares to 162,793 valued at $10.49M in 2018Q4. It also upped Select Sector Spdr Tr (XLV) stake by 4,350 shares and now owns 175,754 shares. Ishares Tr (IEFA) was raised too.

Analysts await Fidelity National Information Services, Inc. (NYSE:FIS) to report earnings on July, 30. They expect $1.79 earnings per share, up 45.53% or $0.56 from last year’s $1.23 per share. FIS’s profit will be $579.30 million for 16.33 P/E if the $1.79 EPS becomes a reality. After $1.64 actual earnings per share reported by Fidelity National Information Services, Inc. for the previous quarter, Wall Street now forecasts 9.15% EPS growth.

Since December 11, 2018, it had 1 buying transaction, and 2 insider sales for $4.13 million activity. Shares for $544,142 were bought by NAVAB ALEXANDAR JR on Thursday, March 21. Another trade for 9,506 shares valued at $1.02M was sold by THOMPSON KATHLEEN T. The insider Mayo Marc M sold 34,826 shares worth $3.66 million.

InflaRx N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing inhibitors using C5a technology primarily in the United States and Europe. The company has market cap of $1.08 billion. The Company’s C5a is an inflammatory mediator involved in the enhancement of a variety of autoimmune and other inflammatory diseases. It currently has negative earnings. The company’s lead product candidate is IFX-1, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that is in the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of other chronic/autoimmune diseases.

More notable recent InflaRx N.V. (NASDAQ:IFRX) news were published by: Nasdaq.com which released: “InflaRx Commences Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe – Nasdaq” on May 14, 2019, also Globenewswire.com with their article: “Report: Exploring Fundamental Drivers Behind Vail Resorts, Unit, DexCom, and InflaRx NV — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on May 08, 2019, Globenewswire.com published: “InflaRx Full Year 2018 Financial & Operating Results – GlobeNewswire” on March 28, 2019. More interesting news about InflaRx N.V. (NASDAQ:IFRX) were released by: Nasdaq.com and their article: “InflaRx (IFRX) Catches Eye: Stock Jumps 7.5% – Nasdaq” published on April 10, 2019 as well as Globenewswire.com‘s news article titled: “InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results – GlobeNewswire” with publication date: November 21, 2018.

Fidelity National Information Services, Inc. (NYSE:FIS) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *